Coalition for Accelerating Standards and Therapies

CDISC, TransCelerate release new standards for diabetes, cardiovascular disease

Wednesday, November 26, 2014

The Clinical Data Interchange Standards Consortium (CDISC), a global nonprofit, and King of Prussia, Pa.-based nonprofit TransCelerate BioPharma have made available therapeutic area standards for diabetes and cardiovascular (CV) disease areas through the Coalition for Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C-Path).

[Read More]